Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;4(2):185-97.
doi: 10.1586/ehm.11.8.

Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health

Kirsten K Ness  1 , Saro H Armenian, Nina Kadan-Lottick, James G Gurney
Affiliations
Review

Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health

Kirsten K Ness et al. Expert Rev Hematol. 2011 Apr.

Abstract

Survival of childhood acute lymphoblastic leukemia (ALL) is one of the greatest medical success stories of the last four decades. Unfortunately, childhood ALL survivors experience medical late effects that increase their risk of morbidity and premature death, often due to heart and vascular disease. Research has helped elucidate the mechanisms and trajectory of direct damage to the heart from treatment exposure, particularly to anthracyclines, and has also contributed knowledge on the influences of related chronic conditions, such as obesity and insulin resistance on heart health in these survivors. This article summarizes the key issues associated with early morbidity and mortality from cardiac-related disease in childhood ALL survivors and suggests directions for interventions to improve long-term outcomes.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

References

    1. Scheurer ME, Bondy ML, Gurney JG. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. PA, USA: Lippincott Williams & Wilkins; 2011. pp. 2–16.

    1. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 2009;360(26):2730–2741. • Comprehensive review of treatment for childhood acute lymphoblastic leukemia.

    1. Shah A, Stiller CA, Kenward MG, Vincent T, Eden TO, Coleman MP. Childhood leukaemia: long-term excess mortality and the proportion ‘cured’. Br. J. Cancer. 2008;99(1):219–223. - PMC - PubMed
    1. Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7(6):489–498. - PubMed
    1. Mariotto AB, Rowland JH, Yabroff KR, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol. Biomarkers Prev. 2009;18(4):1033–1040. - PubMed

Websites

    1. Cancer Research UK. London, UK: Cancer Research; 2010. Cancer in the UK: July 2010. http://info.cancerresearchuk.org/cancerstats/inequalities/index.htm.
    1. The Children’s Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers. www.survivorshipguidelines.org.

Publication types

MeSH terms

Substances